A double-blind augmentation study of levetiracetam in obsessive compulsive disorder.

Trial Profile

A double-blind augmentation study of levetiracetam in obsessive compulsive disorder.

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 31 Oct 2014

At a glance

  • Drugs Levetiracetam (Primary) ; Sertraline
  • Indications Obsessive-compulsive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Aug 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov
    • 13 Aug 2008 Planned end date changed from 1 Nov 2007 to 1 Apr 2008 as reported by ClinicalTrials.gov
    • 15 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top